肾肿瘤活检数据集(cT1b-T4-M0期患者)
肾脏肿瘤≥4cm患者的活检数据,评估安全性、准确性及对根治性肾切除术的临床影响。

基本信息
资源简介
肾肿瘤活检数据集(cT1b-T4-M0期患者)
【一句话概览】
本数据集是 figshare 公开的结构化表格数据集,收录 2 个文件、合计 38.93 KB,主题涵盖 Renal neoplasms、tumor biopsy、renal cell carcinoma、oncocytoma、radical nephrectomy,可用于统计建模、特征工程与队列分析,CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management》。配套论文《Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management》发表于 Scandinavian Journal of Urology(2022),DOI:10.1080/21681805.2022.2092549。源站首次发布:2022-06-29。
【数据内容】
源站原始描述:Renal tumor biopsy was provided in patients candidate to radical nephrectomy for a renal mass ≥4 cm, to evaluate treatment deviation. Between 2008 and 2017, 102 patients with a solid renal mass ≥4 cm with no distant metastases underwent preliminary renal tumor biopsy. We investigated the proportion of patients who proceeded with radical nephrectomy, variables predicting non-renal cell carcinoma (RCC) and concordance between biopsy findings and definitive pathology. Median tumor size was 70 mm (I…
【数据结构与技术规格】
文件数 2 个,合计 38.93 KB。Supplementary Table 1 def.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,16.76 KB。Supplementary Table 2.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,22.17 KB。数据集 DOI:10.6084/m9.figshare.20179825.v1。
【主题与分类】
源站学科分类:Space Science、Medicine、Cell Biology、Biotechnology、Immunology、Marine Biology。主题标签:Renal neoplasms、tumor biopsy、renal cell carcinoma、oncocytoma、radical nephrectomy。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://tandf.figshare.com/articles/dataset/Renal_tumor_biopsy_in_patients_with_cT1b-T4-M0_disease_susceptible_to_radical_nephrectomy_analysis_of_safety_accuracy_and_clinical_impact_on_definitive_management/20179825
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management. Taylor & Francis. Nazzani, Sebastiano; Zaborra, Carlotta; Biasoni, Davide; Catanzaro, Mario; Macchi, Alberto; Stagni, Silvia; et al
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management
- DOI:10.6084/m9.figshare.20179825.v1
- 发布日期:2022-06-29
- 文件数:2 个
- 文件总体积:38.93 KB
- 源站页面:https://tandf.figshare.com/articles/dataset/Renal_tumor_biopsy_in_patients_with_cT1b-T4-M0_disease_susceptible_to_radical_nephrectomy_analysis_of_safety_accuracy_and_clinical_impact_on_definitive_management/20179825
命令行下载
curl -L -o "Supplementary Table 1 def.docx" "https://ndownloader.figshare.com/files/36081067"
curl -L -o "Supplementary Table 2.docx" "https://ndownloader.figshare.com/files/36081070"
文件清单
Supplementary Table 1 def.docx(16.76 KB)Supplementary Table 2.docx(22.17 KB)
文件总体积 38.93 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Renal tumor biopsy was provided in patients candidate to radical nephrectomy for a renal mass ≥4 cm, to evaluate treatment deviation.
Between 2008 and 2017, 102 patients with a solid renal mass ≥4 cm with no distant metastases underwent preliminary renal tumor biopsy. We investigated the proportion of patients who proceeded with radical nephrectomy, variables predicting non-renal cell carcinoma (RCC) and concordance between biopsy findings and definitive pathology.
Median tumor size was 70 mm (IQR 55–110). Clinical stage was cT1b in 41, cT2 in 33, cT3 in 25 and cT4 in three patients. A median of three (IQR 2–3) renal tumor biopsies were taken with 16/18 Gauge needles in 97% of cases. Clavien grade I complications occurred in five cases. Malignant tumors were documented in 84 patients: 78 RCCs and six non-RCCs. Fifteen biopsies documented oncocytoma and three were non-diagnostic. Grade was reported in 50 RCCs: 42 (84%) were low and eight (16%) high grade. Eighty-three patients proceeded with radical nephrectomy; six non-RCC malignant tumors underwent combined and/or intensified treatment; 13 of 15 patients with oncocytoma did not undergo radical nephrectomy (eight underwent observation). Definitive pathology confirmed diagnosis in all cases. Grade concordance was 84%, considering two tiers (high vs low grade). No preoperative clinical variable predicted definitive pathology.
Renal tumor biopsy is a safe procedure that leads to radical nephrectomy in most tumors ≥4 cm. Nonetheless, 20% of patients exhibited non-RCC histology. Renal tumor biopsy should be considered in this setting.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.20179825.v1(source: https://tandf.figshare.com/articles/dataset/Renal_tumor_biopsy_in_patients_with_cT1b-T4-M0_disease_susceptible_to_radical_nephrectomy_analysis_of_safety_accuracy_and_clinical_impact_on_definitive_management/20179825)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




